AYAyşegül Yılmaz

Ayşegül Yılmaz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ayşegül Yılmaz has a total of 87 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Canpolat-Karakükcü-Dursun-Poyrazoğlu Pediatride Temel Bilgiler

    by Benhur Şirvan Çetin, Filiz Tubaş, Ayşenur Paç Kısaarslan, Dilek Kafadar, Ahmet Özdemir, Özge Pamukçu Akay, Ali Baykan, Zehra Bayazıt, Fulya Tahan, Derya Altay, et al.

  • The clinical phenotype of Koolen‐de Vries syndrome in Turkish patients and literature review

    by Gokcen Karamik, Beyhan Tuysuz, Esra Isik, Aysegul Yilmaz, Yasemin Alanay, Evrim Cifci Sunamak, Enise Avci Durmusalioglu, Ferda Ozkinay, Gokhan Ozan Cetin, Nuray Ozturk, et al.

    Koolen‐de Vries syndrome (KdVS) is a rare multisystemic disorder caused by a microdeletion on chromosome 17q21.31 including KANSL1 gene or intragenic pathogenic variants in KANSL1 gene. Here, we describe the clinical and genetic spectrum of eight Turkish children with KdVS due to a de novo 17q21.31 deletion, and report on several rare/new conditions. Eight patients from unrelated families aged between 17 months and 19 years enrolled in this study. All patients evaluated by a clinical geneticist, and the clinical diagnosis were confirmed by molecular karyotyping. KdVS patients had some common distinctive facial features. All patients had neuromotor retardation, and speech and language delay. Epilepsy, structural brain anomalies, ocular, ectodermal, and musculoskeletal findings, and friendly personality were remarkable in more than half of the patients. Hypertension, hypothyroidism, celiac disease, and postaxial polydactyly were among the rare/new conditions. Our study contributes to the clinical spectrum of patients with KdVS, while also provide a review by comparing them with previous cohort studies.


  • Nörogenetik Hastalıklarda Klinik Yaklaşım ve Yönetim

    by Ayşegül Yılmaz

    Genetik bozukluklar; zihinsel yetersizlik ve yaygın gelişimsel gerilik gibi nörolojik tabloların etyolojisinde merkezi bir rol oynamaktadır. Hastaların klinik değerlendirmesi, ayrıntılı öykü ve muayene ile başlayıp, kromozom analizi ve mikrodizin gibi geleneksel yöntemlerden tüm ekzom dizileme gibi ileri moleküler tekniklere kadar uzanan kapsamlı bir tanısal süreci gerektirir. Down, Patau ve Klinefelter sendromları gibi çeşitli kromozomal anomaliler ve mikrodelesyon/duplikasyon sendromları, farklı fenotipik özelliklerle karakterize olup, tanısal süreçte çok disiplinli bir yaklaşımı zorunlu kılar. Güncel moleküler genetik analizler, önceki yöntemlerle tanımlanamayan vakaların aydınlatılmasında kritik bir öneme sahiptir. Genetic disorders play a central role in the etiology of neurological conditions such as intellectual disability and global developmental delay. Clinical assessment requires a comprehensive diagnostic process starting with detailed history and physical examination, followed by advanced molecular techniques ranging from traditional chromosomal analysis to whole-exome sequencing. Various chromosomal anomalies, such as Down, Patau, and Klinefelter syndromes, along with diverse microdeletion and duplication syndromes, present unique phenotypic characteristics that demand a multidisciplinary diagnostic approach. Modern molecular genetic tools are increasingly vital for identifying the underlying genetic causes in cases that remain undiagnosed by standard testing.